Hepion Pharmaceuticals Inc (HEPA):企業の財務・戦略的SWOT分析

◆英語タイトル:Hepion Pharmaceuticals Inc (HEPA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH503409FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hepion Pharmaceuticals Inc (Hepion) formerly known as ContraVir Pharmaceuticals Inc, is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its potency and selective index against HBV. It products are used for the treatment of chronic hepatitis B and shingles. Hepion serves atients and healthcare professionals by developing differentiated therapeutic products. The company operates in the US. Hepion is headquartered in Edison, New Jersey, the US.

Hepion Pharmaceuticals Inc Key Recent Developments

Mar 22,2021: Hepion Pharmaceuticals Announces Presentation and Panel Participation at the Benzinga Global Biotech Small Cap Conference
Oct 05,2020: Hepion Pharmaceuticals introduces proprietary A.I. platform for drug development & announces creation of clinical pharmacology analytics team
Jun 10,2020: Hepion Pharmaceuticals welcomes industry veteran and drug development expert, Dr. Peter Wijngaard, to its Board of Directors
Apr 13,2020: Hepion Pharmaceuticals receives loan under Paycheck Protection Program

This comprehensive SWOT profile of Hepion Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Hepion Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Hepion Pharmaceuticals Inc – Key Information
Hepion Pharmaceuticals Inc – Overview
Hepion Pharmaceuticals Inc – Key Employees
Hepion Pharmaceuticals Inc – Key Employee Biographies
Hepion Pharmaceuticals Inc – Key Operational Heads
Hepion Pharmaceuticals Inc – Major Products and Services
Hepion Pharmaceuticals Inc – History
Hepion Pharmaceuticals Inc – Company Statement
Hepion Pharmaceuticals Inc – Locations And Subsidiaries
Hepion Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Hepion Pharmaceuticals Inc – Business Description
Hepion Pharmaceuticals Inc – Corporate Strategy
Hepion Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Hepion Pharmaceuticals Inc – Strengths
Hepion Pharmaceuticals Inc – Weaknesses
Hepion Pharmaceuticals Inc – Opportunities
Hepion Pharmaceuticals Inc – Threats
Hepion Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Hepion Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Hepion Pharmaceuticals Inc, Key Information
Hepion Pharmaceuticals Inc, Key Ratios
Hepion Pharmaceuticals Inc, Share Data
Hepion Pharmaceuticals Inc, Major Products and Services
Hepion Pharmaceuticals Inc, History
Hepion Pharmaceuticals Inc, Key Employees
Hepion Pharmaceuticals Inc, Key Employee Biographies
Hepion Pharmaceuticals Inc, Key Operational Heads
Hepion Pharmaceuticals Inc, Other Locations
Hepion Pharmaceuticals Inc, Subsidiaries
Hepion Pharmaceuticals Inc, Key Competitors
Hepion Pharmaceuticals Inc, SWOT Analysis
Hepion Pharmaceuticals Inc, Ratios based on current share price
Hepion Pharmaceuticals Inc, Annual Ratios
Hepion Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Hepion Pharmaceuticals Inc (HEPA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • California Cryobank-製薬・医療分野:企業M&A・提携分析
    Summary California Cryobank (CCB) is a healthcare service provider that offers reproductive, stem cell and donor selection services. The center offers services such as donor semen, pricing, donor information subscriptions, graduate donors, donor information, consultation services, genetic services, …
  • EnBW Energie Baden-Wurttemberg AG (EBK):企業の財務・戦略的SWOT分析
    EnBW Energie Baden-Wurttemberg AG (EBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Nordea Private Banking:企業の戦略・SWOT・財務情報
    Nordea Private Banking - Strategy, SWOT and Corporate Finance Report Summary Nordea Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Chrono Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Chrono Therapeutics Inc (CTI) is a personalized medicine manufacturer that provides programmable passive transdermal drug delivery products. The company provides smartstop, a programmable smoking cessation therapy that helps people to quit smoking and improve cessation outcomes. Its wearable …
  • Acasti Pharma Inc (ACST):製薬・医療:M&Aディール及び事業提携情報
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc, is a biopharmaceutical company that conducts research, development, and commercialization of krill oil-based forms of omega-3 fatty acids. The company develops phospholipid therapies for abnormalities in bl …
  • Boehringer Ingelheim GmbH:企業の戦略・SWOT・財務分析
    Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report Summary Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Isramco Inc (ISRL):企業の財務・戦略的SWOT分析
    Summary Isramco Inc (Isramco), a subsidiary of Israel Oil Company Ltd, is an oil and gas company that offers exploration, production and development of oil and natural gas properties. The company acquires, explores, develops and produces oil and natural gas resources. It offers services such as work …
  • PolyOne Corp (POL):企業の財務・戦略的SWOT分析
    PolyOne Corp (POL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • InterGen:企業の戦略的SWOT分析
    InterGen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Formula Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Formula Pharmaceuticals Inc (Formula Pharmaceuticals) is an oncology company that develops chimeric antigen receptor (CAR) immunotherapy for oncology and autoimmune diseases. The company’s pipeline products include CIK-CAR.CD19, used as B-lymphocyte surface antigen; CIK-CAR.CD33, used for th …
  • Cytokinetics Inc (CYTK):製薬・医療:M&Aディール及び事業提携情報
    Summary Cytokinetics Inc (Cytokinetics) is a late stage biopharmaceutical company, which discovers, develops, and commercializes muscle activators for the treatment of diseases associated with reduced muscle performance. The company’s pipeline encompasses omecamtiv mecarbil, a novel cardiac myosin a …
  • Abzena Plc (ABZA):企業の財務・戦略的SWOT分析
    Summary Abzena Plc (Abzena), formerly Polytherics Group Ltd, is a life science company that provides complementary services and technologies to enable the selection, development and manufacture of biopharmaceuticals products based on antibodies and other proteins. The company's technologies include …
  • Synthos SA:企業の戦略的SWOT分析
    Synthos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Integrated BioTherapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Integrated BioTherapeutics Inc (IBT) is a biotechnology company that discovers novel vaccines and therapeutics for infectious diseases. The company's products include polyclonal and monoclonal antibodies raised against various emerging pathogens, vaccines and therapeutics against bacteria, p …
  • Apotex Inc:企業の戦略的SWOT分析
    Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Hovid Berhad (HOVID):企業の財務・戦略的SWOT分析
    Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Taubman Centers Inc (TCO):企業の財務・戦略的SWOT分析
    Taubman Centers Inc (TCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China Petroleum & Chemical Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    China Petroleum & Chemical Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary China Petroleum & Chemical Corp (Sinopec Corp), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and …
  • PDC Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    PDC Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary PDC Energy Inc (PDC Energy) is an oil and gas company that offers production, development, exploration and marketing of crude oil, natural gas and natural gas liquids. The company provides horizontal …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆